维普期刊资源整合服务平台（V6.5）

692篇 您的检索式：作者名="OKAMOTO I"

选中清除导出查看参考文献查看引证文献引用追踪共35页首页上一页第1页下一页末页 /35 跳转

	题名	作者	年代	出处	被引量
1	Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy 显示文摘	Okamoto I	2010	FEBS J2010，277，2：	1
2	Intermetallic compounds formed during brazing of titanium with aluminium filler metals 显示文摘	Takemoto T Okamoto I	1988	Journal of Materials Science1988，23，：	1
3	Lapa- roscopic lymph node dissection around the inferior mesenteric artery for cancer in the lower sigmoid colon and rectum:is 193 lymph node dissection with preservation of the left colic artery feasible 显示文摘	KOBAYASH I M OKAMOTO K NAMIKAWA T	2006	Surg Endosc2006，，20：	1
4	Overcoming erlotinib resistance in EGFR mutation-positive non-small cell lung cancer cells by targeting survivin显示文摘	Okamoto K Okamoto I Hatashita E	2012	Mol Cancer Ther2012，11，1：	1
5	Phase I and pharmaco- kinetic study of ammbiein, a synthetic 9 - aminoanthraeyeline, in patients with refractory or relapsed lung cancer显示文摘	Okamoto I Hamada A Matsunaga Y	2006	Cancer Chemoth- er Pharmacol2006，57，：	1
6	PhaseⅢstudy comparing the effects of carboplatin plus S-1 and carboplatin plus paclitaxel in chemotherapy-naive patients with advanced non-small cell lung cancer:An updated report of the LETS study(WJTOG3605)显示文摘	Hirashima T Okamoto I Yoshioka H	2011	J Clin Oncol2011，，：	1
7	Sphingosine-l-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice显示文摘	Wang F Okamoto Y Inoki I	2010	J Clin Invest2010，120，：	1
8	Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer withepidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial( WJTOG0403 ) 显示文摘	Tamura K Okamoto I Kashii T	2008	Br J Cancer2008，98，5：	1
9	High dose rate intracavitary brachytherapy for recurrent or residual lesions in the vaginal cuff: results in post-hysterectomy patients with carcinoma of the cervix 显示文摘	Ogino I Kitamura T Okamoto N	2001	Int J Gynecol Cancer2001，11，1：	1
10	Diffuse alveolar damage after ZD1839 therapy in a patient with nonsmall cell lung cancer显示文摘	OKAMOTO I FUJII K MATSUMOTO M	2003	Lung Cancer2003，40，3：	1
11	Wettability of silicon carbide by aluminium, copper and silver显示文摘	Shimbo M Naka M Okamoto I	1989	Journal of Materials Science Letters1989，，8：	1
12	Phase I/II study of a S-1plus carboplatin(CBDCA)in patients with advanced non-smallcell lung cancer(NSCLC)显示文摘	Tamura K Okamoto I Ozaki T	2008	Ann Oncol2008，19，10：	1
13	Calcium influx triggers the sequential Proteolysis of extrace\|lular and cytoPlasmic domains of E-cadherin, leading to loss of beta-catenin from cell-cell contacts显示文摘	Ito K Okamoto I Araki N	1999	Oncogene1999，18，50：	1
14	Resolution of racemic compounds by optically active poly(triphenylmethyl methacrylate)显示文摘	Yuki H Okamoto Y Okamoto I	1980	Am Chem Soc1980，102，：	1
15	Production of Androgenetic diploids in amago salmon Oncorhynchus masou ishikawae 显示文摘	Nagoya H Okamoto H Nakayama I	1996	Fish Sci1996，62，3：	1
16	Ovarian clear cell adenofibromatous tumor: report of 2 cases显示文摘	Tsurunaga I Iwai E Okamoto Y	1992	Nippon Sanka Eujinka Gakkai Zasshi1992，44，1：	1
17	Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer显示文摘	Takezawa K Okamoto I Okamoto W	2011	Br J Cancer2011，104，10：	1
18	Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CDS-positive in comparison with CDS-negative diffuse large B-cell lymphoma 显示文摘	Niitsu N Okamoto M Tamaru 1 I	2010	Ann Oncol2010，21，10：	1
19	Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib显示文摘	Ando M Okamoto I Yamamoto N	2006	J Clin Oncol2006，24，16：	1
20	Successful treatment of primary pulmonary angiosarcoma 显示文摘	Kojima K Okamoto I Ushijima S	2003	Chest2003，124，6：	1

返回顶部每页显示：

共35页首页上一页第1页下一页末页 /35 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示